In a different study, treatment of ApoE-/- mice with an AT1 receptor antagonist and simultaneous infusion with angiotensin II inhibited progression of atherosclerosis by decreasing the expression of pro-inflammatory markers and ROS production from the endothelium [282]. This evidence concerns the gene AGTR1 and atherosclerosis.